Hongming Chen - Jun 29, 2021 Form 4 Insider Report for Kala Pharmaceuticals, Inc. (KALA)

Role
CHIEF SCIENTIFIC OFFICER
Signature
/s/ Eric Trachtenberg, Attorney-in-Fact
Stock symbol
KALA
Transactions as of
Jun 29, 2021
Transactions value $
-$30,847
Form type
4
Date filed
6/30/2021, 05:30 PM
Previous filing
Jun 29, 2021
Next filing
Oct 28, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KALA Common Stock Sale -$30.8K -5.55K -2.31% $5.56 235K Jun 29, 2021 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.53 to $5.60, inclusive. The reporting person undertakes to provide to Kala Pharmaceuticals, Inc., any security holder of Kala Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F3 Includes 91,666 unvested RSUs.